As shown in Fig. 6A, disruption of SIRT1 expression significantly decreased the proliferation of OxPhos-DLBCL cell lines (K422, Ly4 and Toledo), irrespective of their TP53 mutation status (Supplementary Table S5). This evidence concerns the gene SIRT1 and diffuse large B-cell lymphoma.